Risk of Arterial and Venous Thromboembolic Events with Bevacizumab, an Antibody against Vascular Endothelial Growth Factor A (VEGF-A): A Systematic Review and Meta-Analysis. (2020). Global Journal of Medical Research, 20(B1), 71-85. https://medicalresearchjournal.org/index.php/GJMR/article/view/1952